Condition
Rectal Neuroendocrine Tumor
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Not Yet Recruiting2
Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07759960Not ApplicableRecruitingPrimary
Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors
NCT06901856Not ApplicableNot Yet RecruitingPrimary
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
NCT05429216Not ApplicableNot Yet RecruitingPrimary
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
NCT03982264Not ApplicableUnknownPrimary
Endoscopic Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm
Showing all 4 trials